Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Congenital disorder of glycosylation type I
SSR3-CDG
A congenital disorder of glycosylation with a SSR3 deficiency that affects the brain, lungs and gastrointestinal system, and presents with clinical phenotypes such as seizures, intellectual disability, developmental delay, microcephaly and abnormal brain structure.
This condition has no sub-types.